Infectious Diseases News and Research

RSS

Insilico Medicine's leadership to address key challenges in AI drug discovery at BIO Convention

Leadership from clinical stage artificial intelligence (AI)-powered drug discovery company Insilico Medicine ("Insilico") will attend the BIO International Convention in San Diego June 3-6 and present on key issues facing AI drug discovery.

23 May 2024

100-year-old BCG vaccine protects individuals with type 1 diabetes from infectious diseases

In new research, investigators at Massachusetts General Hospital (MGH) show that the 100-year-old Bacillus Calmette-Guérin (BCG) vaccine, originally developed to prevent tuberculosis, protects individuals with type 1 diabetes from severe COVID-19 disease and other infectious diseases.

22 May 2024

Health experts call for tighter biosecurity measures to monitor avian influenza

Health experts are calling for tighter biosecurity measures in global poultry production, from farms to markets, to monitor bird flu (avian influenza) following its spread among 888 cases of human infection with the avian influenza virus, also known as H5N1, have been reported from 23 countries, of which 463 were fatal, according to the World Health Organization (WHO).

21 May 2024

Human body lice more efficient at transmitting Yersinia pestis than previously thought

A new laboratory study suggests that human body lice are more efficient at transmitting Yersinia pestis, the bacterium that causes plague, than previously thought, supporting the possibility that they may have contributed to past pandemics.

21 May 2024

New discovery could lead to a treatment for visceral leishmaniasis

A discovery by Simona Stäger's team could help come up with a treatment to the most serious form of leishmaniasis.

21 May 2024

ERS Genomics and IRBM sign CRISPR/Cas9 license agreement

ERS Genomics Limited (‘ERS’), the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, today announced a non-exclusive CRISPR/Cas9 license agreement. The agreement grants IRBM access to ERS’ CRISPR/Cas9 patent portfolio.

From ERS Genomics 21 May 2024

New mechanism discovered for Chagas disease-induced heart damage

Jyothi Nagajyothi, Ph.D. and her laboratory at the Hackensack Meridian Center for Discovery and Innovation (CDI) have identified what may be the main mechanism for how chronic Chagas Disease, a parasitic infection affecting millions of people worldwide, can cause irreversible and potentially fatal heart damage.

20 May 2024

Insilico and NVIDIA unveil new LLM transformer for solving biological and chemical tasks

In a new paper, researchers from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine ("Insilico"), in collaboration with NVIDIA, present a new large language model (LLM) transformer for solving biological and chemical tasks called nach0.

20 May 2024

Could python farming be the next big thing in sustainable livestock production?

A study in Scientific Reports suggests that python farming could be a sustainable and efficient livestock alternative, showing promising growth rates and high production efficiency for commercial use.

19 May 2024

Antibiotic overuse linked to poor record-keeping in healthcare settings

A lack of detailed record-keeping in clinics and emergency departments may be getting in the way of reducing the inappropriate use of antibiotics, a pair of new studies by a pair of University of Michigan physicians and their colleagues suggests.

17 May 2024

Study confirms strong barrier preventing chronic wasting disease transmission to humans

A new study of prion diseases, using a human cerebral organoid model, suggests there is a substantial species barrier preventing transmission of chronic wasting disease (CWD) from cervids-;deer, elk and moose-;to people.

17 May 2024

Study reveals positive impact of repeat COVID-19 vaccinations

Health-care workers received the first doses of the COVID-19 vaccine in December 2020.

17 May 2024

Rutgers researchers expose war's toll on Ukraine's hospitals

Rutgers researchers, aided by international collaborators, have tracked the devastation war has made on Ukraine's hospital system.

17 May 2024

Vaccine candidate spurs elusive type of broadly neutralizing HIV antibodies

An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.

17 May 2024

UVA develops big data tool to combat childhood diarrhea

University of Virginia researchers are developing a flexible online tool for navigating information used in the fight to save children from deadly diarrheal diseases by identifying transmission hotspots and accelerating the deployment of treatments and new vaccines.

17 May 2024

Clean needles save lives. In some states, they might not be legal.

Kim Botteicher hardly thinks of herself as a criminal. On the main floor of a former Catholic church in Bolivar, Pennsylvania, Botteicher runs a flower shop and cafe.

17 May 2024

H5N1 avian flu strain jumps to seals in Quebec, raising zoonotic fears

Study describes the unusual mortality of gray and harbor seals in Quebec due to a highly pathogenic avian influenza A (H5N1) strain, raising concerns about potential zoonotic spillover.

17 May 2024

Pre-vaccine COVID-19: US study reveals hospitalization rate of 5.7% and fatality rate of 1.7%

Study estimates COVID-19 hospitalization and mortality rates in the US during the pre-vaccination period, revealing significant age and racial disparities in outcomes.

17 May 2024

SMART researchers identify key mechanism behind artemisinin resistance in malaria

Researchers from the Antimicrobial Resistance (AMR) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, in collaboration with Massachusetts Institute of Technology (MIT), Columbia University Irving Medical Center (CUIMC), and Nanyang Technological University, Singapore (NTU Singapore), have discovered a link between malaria parasites' ability to develop resistance to antimalarial drugs – specifically artemisinin (ART) – through a cellular process called transfer Ribonucleic acid (tRNA) modification.

16 May 2024

Azenta opens the doors to its new genomics laboratory in Oxford, UK

Azenta, Inc. today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further in the UK market.

From Azenta Life Sciences 16 May 2024